KR860006543A - 인터페론-γ의 제조방법 - Google Patents
인터페론-γ의 제조방법 Download PDFInfo
- Publication number
- KR860006543A KR860006543A KR1019860000675A KR860000675A KR860006543A KR 860006543 A KR860006543 A KR 860006543A KR 1019860000675 A KR1019860000675 A KR 1019860000675A KR 860000675 A KR860000675 A KR 860000675A KR 860006543 A KR860006543 A KR 860006543A
- Authority
- KR
- South Korea
- Prior art keywords
- strain
- gram
- belonging
- expression system
- positive
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
- C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 pGC 303의 제한효소지도이며, 제3도는 이 콜라이 발현 벡터의 작성 공정을 나타낸다. 숫자는 본문중의 긍정번호를 나타낸다.
제5도는 pYI 7-1과 IFN-γ유전자와의 연결에 의한 pIr amy5의 작성공정을 나타내며,
Claims (4)
- 발현계 유전자로서 그람양성 균주로부터 유도된 α-아미라제 프로모터 부분을 함유하는 발현계 및 숙주로서 그람 음성균주를 사용하여 인터페론-γ를 제조하는 방법.
- 제1항에서, 그람양성 균주가 바실루스 속에 속하는 균주인 방법.
- 제2항에서 바실루스 속에 속하는 균주가 바실루스 나토종에 속하는 균주인 방법.
- 제1-4항에서 그람 음성 균주가 이 콜라이의 균주인 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18991 | 1985-02-02 | ||
JP60018991A JPS61177996A (ja) | 1985-02-02 | 1985-02-02 | インタ−フエロン−γの製造法 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR860006543A true KR860006543A (ko) | 1986-09-13 |
Family
ID=11987034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019860000675A KR860006543A (ko) | 1985-02-02 | 1986-01-31 | 인터페론-γ의 제조방법 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0190686A3 (ko) |
JP (1) | JPS61177996A (ko) |
KR (1) | KR860006543A (ko) |
ES (1) | ES8800361A1 (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61135599A (ja) * | 1984-12-04 | 1986-06-23 | Green Cross Corp:The | 異種蛋白質の製造法 |
JP2791418B2 (ja) | 1987-12-02 | 1998-08-27 | 株式会社ミドリ十字 | 異種蛋白質の製造方法、組換えdna、形質転換体 |
BG52073B2 (en) * | 1990-01-24 | 1996-04-30 | Inst Molekuljarna Biolog | Method for the preparation of recombinant human noncystein -interferon, free of n-end methionine |
HU214698B (hu) * | 1992-04-09 | 1998-06-29 | Gyógyszerkutató Intézet Kft. | Eljárás rekombináns deszulfátó-hirudin HV-1 peptidek előállítására |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI64813C (fi) * | 1980-12-31 | 1984-01-10 | Ilkka Antero Palva | Foerfarande foer producering av ett utvalt aeggviteaemne och vid foerfarandet anvaenda rekombinantplasmidvektorer |
JPS6027388A (ja) * | 1983-07-22 | 1985-02-12 | Green Cross Corp:The | プラスミツド |
JPS61135599A (ja) * | 1984-12-04 | 1986-06-23 | Green Cross Corp:The | 異種蛋白質の製造法 |
-
1985
- 1985-02-02 JP JP60018991A patent/JPS61177996A/ja active Pending
-
1986
- 1986-01-30 ES ES551424A patent/ES8800361A1/es not_active Expired
- 1986-01-31 EP EP86101306A patent/EP0190686A3/en not_active Withdrawn
- 1986-01-31 KR KR1019860000675A patent/KR860006543A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ES8800361A1 (es) | 1987-10-16 |
ES551424A0 (es) | 1987-10-16 |
JPS61177996A (ja) | 1986-08-09 |
EP0190686A2 (en) | 1986-08-13 |
EP0190686A3 (en) | 1988-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3685764T2 (de) | Antibiotikum hergestellt von lysobacter sp. sc 14,067. | |
KR840005483A (ko) | A47934 항생물질의 제조방법 | |
KR860006543A (ko) | 인터페론-γ의 제조방법 | |
KR890004726A (ko) | 마이코플라즈마 백신 | |
KR840003696A (ko) | 2-케토-l-굴론산의 제조방법 | |
GB1490510A (en) | Organosiloxanes | |
GB1137170A (en) | Method of synthesizing in vitro biologically active intact nucleic acid and new biologically active products and replicases therefor and method of making such replicases | |
DE3786837D1 (de) | Motorgeschwindigkeitsregelsystem. | |
KR890008325A (ko) | 아미노디옥시 만니톨의 제법 | |
KR830002749A (ko) | 부티로락톤의 제조방법 | |
ES8302097A1 (es) | Un metodo para producir enduracidina | |
GB1475624A (en) | Polypeptide | |
JPS5315491A (en) | Preparation of novel nucleicacidase | |
KR840007437A (ko) | 항생제 a 51568 인자 a 및 b의 제조방법 | |
KR850008492A (ko) | 트랜스, 트랜스-8,10-도데카디엔-1-일옥시실란의 제조방법 | |
DE3364348D1 (en) | Erythromycin d and esters thereof by fermentation | |
KR900006517A (ko) | 항생제 pb-6042류 | |
KR830010197A (ko) | 나라신의 제조방법 | |
KR830005357A (ko) | 나라신의 제조방법 | |
KR880001822A (ko) | 미생물에 의한 5'-구아닐산의 제조방법 | |
KR870008023A (ko) | 락트 알부민 하이드로리 세이트의 첨가에 의한 인터페론의 생산 증강법 | |
GB1440289A (en) | Blood control standard | |
KR870002159A (ko) | 밀디오마이신의 제조법 | |
KR880001824A (ko) | 미생물에 의한 5'-이노신산의 제조방법 | |
Hartman | Getting the most from VAX/VMS MAIL. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |